GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Pretax Margin %

3SBio, (FRA:YFK) Pretax Margin % : 33.33% (As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. 3SBio,'s Pre-Tax Income for the six months ended in Dec. 2016 was €68.2 Mil. 3SBio,'s Revenue for the six months ended in Dec. 2016 was €204.5 Mil. Therefore, 3SBio,'s pretax margin for the quarter that ended in Dec. 2016 was 33.33%.

The historical rank and industry rank for 3SBio,'s Pretax Margin % or its related term are showing as below:

FRA:YFK' s Pretax Margin % Range Over the Past 10 Years
Min: 19.77   Med: 28.98   Max: 47.18
Current: 30.31


FRA:YFK's Pretax Margin % is not ranked
in the Biotechnology industry.
Industry Median: -157.6 vs FRA:YFK: 30.31

3SBio, Pretax Margin % Historical Data

The historical data trend for 3SBio,'s Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Pretax Margin % Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.18 19.77 31.85 35.14 30.39

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.69 35.21 35.07 27.02 33.33

Competitive Comparison of 3SBio,'s Pretax Margin %

For the Biotechnology subindustry, 3SBio,'s Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio,'s Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s Pretax Margin % distribution charts can be found below:

* The bar in red indicates where 3SBio,'s Pretax Margin % falls into.



3SBio, Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

3SBio,'s Pretax Margin for the fiscal year that ended in Dec. 2016 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=116.458/383.223
=30.39 %

3SBio,'s Pretax Margin for the quarter that ended in Dec. 2016 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2016 )/Revenue (Q: Dec. 2016 )
=68.153/204.459
=33.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3SBio,  (FRA:YFK) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


3SBio, Pretax Margin % Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines